Pharmaceuticals, Biotechnology and Life Sciences
Partnership with Huadong Medicine Accelerates Development and Commercialization of Mirvetuximab Soravtansine in Greater China Encouraging Anti-Tumor Activity and Tolerability Data…
Additional Capital Expected to Extend Company’s Operating Runway into At Least 2023 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, (Nasdaq: EPZM), a fully integrated,…
Additional Capital Expected to Extend Company’s Operating Runway into At Least 2023 CAMBRIDGE, Mass.–(BUSINESS WIRE)–Epizyme, (Nasdaq: EPZM), a fully integrated,…
‒ Q3 2020 Net Revenue of $519 million; GAAP Net Loss of $(9) million; Diluted Loss per Share of $(0.06)…
‒ Q3 2020 Net Revenue of $519 million; GAAP Net Loss of $(9) million; Diluted Loss per Share of $(0.06)…
DUBLIN–(BUSINESS WIRE)–The “Nitric Oxide – Therapeutics, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
DUBLIN–(BUSINESS WIRE)–The “Nitric Oxide – Therapeutics, Markets and Companies” report from Jain PharmaBiotech has been added to ResearchAndMarkets.com’s offering. This…
LACHEN, Switzerland–(BUSINESS WIRE)–#ACR20–Octapharma announces that the final results from the phase III ProDERM study will be presented at the American…
LONDON–(BUSINESS WIRE)–#GlobalNeuroscienceAntibodiesandAssaysMarket–The neuroscience antibodies and assays market is poised to grow by USD 1.36 billion during 2020-2024, progressing at a…
Trial results indicate treatment with CT-P59 resulted in at least 44% faster recovery time when compared with placebo No patients…